Evidence mapPaperPMID 40086622Full record

ArticleNeuropharmacology2025

Exogenous oral application of PYY and exendin-4 impacts upon taste-related behavior and taste perception in wild-type mice.

Satya Iyer, Jean-Pierre Montmayeur, Sergei Zolotukhin, Cedrick D Dotson

Abstract read
In one paragraph

Article in Neuropharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Satya IyerNeuroscience Institute, Georgia State University, Atlanta, GA, 30303, USA.
Jean-Pierre MontmayeurNeuroscience Institute, Georgia State University, Atlanta, GA, 30303, USA.
Sergei ZolotukhinDepartment of Pediatrics, University of Florida College of Medicine, Gainesville, FL, 32610, USA.
Cedrick D DotsonNeuroscience Institute, Georgia State University, Atlanta, GA, 30303, USA. Electronic address: cdotson@gsu.edu.

Funding

rAAV-Mediated Metabolic Engineering in VivoR01DK062302 · UNIVERSITY OF FLORIDA · 2003 to 2005
$785k
NIDCD NIH HHS P30 DC010763NIDCD NIH HHS R01 DC012819NIDDK NIH HHS R01 DK062302
6 · The paper itself

Abstract

Several gut peptides have been implicated in feeding and body mass accumulation. Glucagon-like peptide 1 (GLP-1) and peptide tyrosine-tyrosine (PYY) have been shown to mediate satiety and reduce food intake. While systemic administration of such peptides has been explored as a therapy for metabolic disease, the effects of these hormones on taste signaling should also be considered given the importance of taste to feeding decisions and considering the fact that components of these signaling systems are expressed in cells of the peripheral gustatory system. We previously demonstrated that genetic disruption of PYY signaling in mice can impact on taste responsiveness and feeding and that viral expression of PYY in the salivary glands of PYY knockout mice can rescue responsiveness. The present work uses adeno-associated virus-mediated salivary gland treatment with both GLP-1 receptor agonist exendin-4 and/or PYY encoding vectors to explore the effect of stimulating these orally present signaling systems on taste-related behavioral responsiveness in male wild-type mice with intact peptide signaling systems. Results showed a significant effect of salivary gland treatment on responsiveness to multiple taste qualities. Data gathered from taste bud cells in vitro suggest that these peptides directly influence the responsiveness of these primary sensory cells. Collectively, these findings show that taste perception can be modulated by the exogenous application of satiety peptides in wild-type mice and suggest that the taste bud is a promising substrate for food intake modulation.

Indexed as

ExenatidePeptide YYTasteTaste PerceptionAdministration, OralAnimalsMaleMiceMice, Inbred C57BLMice, KnockoutTaste BudsExenatidePeptide YYAAVExendin-4GLP-1IntralipidLicking behaviorPYYTaste

Identifiers

PMID40086622
PMCPMC12042652

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.